Deucravacitinib

CAS No.

1609392-27-9

MDL No.

MFCD31715455

C₂₀H₂₂N₈O₃

425.50

InChI Key

BZZKEPGENYLQSC-FIBGUPNXSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1609392-27-9
Product Name	Deucravacitinib

Biological Targets

TYK2

Associated Conditions

hidradenitis suppurativa·ulcerative colitis·cutaneous lupus erythematosus·immune system disease·Pyoderma·

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Deucravacitinib

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

TYK-ing all the boxes in psoriasis.

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Tyrosine Kinase 2 (TYK2) Allosteric Inhibitors To Treat Autoimmune Diseases.

Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165.

Documentation

Similar Products

TYK2 ligand 1

Envudeucitinib

Bms-986202